Summary
Guaifenesin is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
The Global Guaifenesin API market is estimated to reach xxx Million USD in 2017. In the report, HeyReport says Pharmaceuticals dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of purity, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
By Purity
98%-99% Type
>99% Type
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
Based on Application, the report describes major Application share of regional market. Application mentioned as follows:
Pharmaceuticals
Personal Care
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Biesterfeld
Seven Star Pharma
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm
Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Purity
1.2.1.1 98%-99% Type
1.2.1.2 >99% Type
1.2.2 by Application
1.2.2.1 Pharmaceuticals
1.2.2.2 Personal Care
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Purity
4.1 Market Size
4.1.1 Global 98%-99% Type Market, 2011-2016
4.1.2 Global >99% Type Market, 2011-2016
4.2 Market Forecast
4.2.1 Global 98%-99% Type Market Forecast, 2017-2022
4.2.2 Global >99% Type Market Forecast, 2017-2022
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Guaifenesin API in Pharmaceuticals Market, 2011-2016
5.1.2 Guaifenesin API in Personal Care Market, 2011-2016
5.2 Market Forecast
5.2.1 Guaifenesin API in Pharmaceuticals Market Forecast, 2017-2022
5.2.2 Guaifenesin API in Personal Care Market Forecast, 2017-2022
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Guaifenesin API Market, 2011-2016
6.1.1.2 Asia-Pacific Guaifenesin API Market by Purity
6.1.1.3 Asia-Pacific Guaifenesin API Market by Application
6.1.2 North America
6.1.2.1 North America Guaifenesin API Market, 2011-2016
6.1.2.2 North America Guaifenesin API Market by Purity
6.1.2.3 North America Guaifenesin API Market by Application
6.1.3 Europe
6.1.3.1 Europe Guaifenesin API Market, 2011-2016
6.1.3.2 Europe Guaifenesin API Market by Purity
6.1.3.3 Europe Guaifenesin API Market by Application
6.1.4 South America
6.1.4.1 South America Guaifenesin API Market, 2011-2016
6.1.4.2 South America Guaifenesin API Market by Purity
6.1.4.3 South America Guaifenesin API Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Guaifenesin API Market, 2011-2016
6.1.5.2 Middle East & Africa Guaifenesin API Market by Purity
6.1.5.3 Middle East & Africa Guaifenesin API Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2017-2022
6.2.2 North America Market Forecast, 2017-2022
6.2.3 Europe Market Forecast, 2017-2022
6.2.4 South America Market Forecast, 2017-2022
6.2.5 Middle East & Africa Market Forecast, 2017-2022
7 Market Competitive
7.1 Global Guaifenesin API Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Granules
8.1.1 Profile
8.1.2 Business Performance
8.2 Synthokem Labs
8.2.1 Profile
8.2.2 Business Performance
8.3 Haizhou Pharma
8.3.1 Profile
8.3.2 Business Performance
8.4 Yuan Cheng Group
8.4.1 Profile
8.4.2 Business Performance
8.5 Stellar Chemical
8.5.1 Profile
8.5.2 Business Performance
8.6 Biesterfeld
8.6.1 Profile
8.6.2 Business Performance
8.7 Seven Star Pharma
8.7.1 Profile
8.7.2 Business Performance
8.8 Camlin Fine Science
8.8.1 Profile
8.8.2 Business Performance
8.9 Gennex Lab
8.9.1 Profile
8.9.2 Business Performance
8.10 Iwaki Seiyaku
8.10.1 Profile
8.10.2 Business Performance
8.11 Pan Drugs
8.12 Delta Synthetic
8.13 Smart Pharm
9 Conclusion
Guaifenesin API
Guaifenesin API
×